Showing results (31-40 of 163) with videos related to

Sort By:
Pageof 17
Cancer Immunology, Immunotherapy : CII|July 23, 2011
A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironmentGabriele Cantini, Federica Pisati, Alfonso Mastropietro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 2, 2012
Central nervous system lymphoma occurring in a patient with neurofibromatosis type 1 (von Recklinghausen disease)Marica Eoli, Donata Bianchessi, Anna Luisa Di Stefano, et al.
Molecular and Cellular Neurosciences|August 25, 2009
Reelin affects chain-migration and differentiation of neural precursor cellsSimone Massalini, Serena Pellegatta, Federica Pisati, et al.
Cell Death & Disease|August 11, 2017
Identification and characterization of a new source of adult human neural progenitorsJinan Behnan, Biljana Stangeland, Tiziana Langella, et al.
Oncoimmunology|July 29, 2016
The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant gliomaSara Pessina, Gabriele Cantini, Dimos Kapetis, et al.
International Journal of Molecular Sciences|November 28, 2019
ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell ImmunotherapySerena Pellegatta, Natalia Di Ianni, Sara Pessina, et al.
Cells|March 29, 2023
Targeting Post-Translational Modifications to Improve Combinatorial Therapies in Breast Cancer: The Role of FucosylationGabriele Antonarelli, Valentina Pieri, Francesca Maria Porta, et al.
Molecular Cancer|October 8, 2004
Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastomaPatrizia Tunici, Lorena Bissola, Elena Lualdi, et al.
Cancer Genomics & Proteomics|August 7, 2009
MGMT promoter hypermethylation in a series of 104 glioblastomasMarta Mellai, Valentina Caldera, Laura Annovazzi, et al.
Clinical Nuclear Medicine|February 13, 2026
18F-DOPA PET Silence in High-grade Glioma Subtype F: A Distinct Metabolic PhenotypeChloé Quéré, Franck Bielle, Alberto Picca, et al.
Pageof 17